Pfizer Reveals Data from P-III (BREAKWATER) trial of Braftovi Regimen in Patients with Metastatic Colorectal Cancer
Shots: Pfizer reported topline data of P-III (BREAKWATER) study assessing Braftovi...
Algiax Pharmaceuticals Reports Topline Data from P-IIa Trial of AP-325 for Neuropathic Pain
Shots: Algiax reported topline data from the P-IIa PoC trial assessing AP-325 (GAB...
Daiichi Sankyo and AstraZeneca Dose the First Patient with Adjuvant Datroway in P-III (TROPION-Lung12) Trial for Adenocarcinoma NS...
Shots: Daiichi & AstraZeneca have dosed first patient with adj. Datroway (6 mg...
Ethris Reports Topline Data from P-I trial of ETH47 for Uncontrollable Asthma
Shots: Ethris presented full topline data from P-I trial of ETH47 (nasal) in 40 he...
ITM Reports Topline Data from P-III (COMPETE) Trial of ITM-11 to Treat Grade 1 or Grade 2 Gastroenteropancreatic Neuroendocrine Tu...
Shots: The P-III (COMPETE) trial assessed ITM-11 (7.5 GBq + nephroprotective amino...
